Metabonomics exposes metabolic biomarkers of Crohn's disease by 1HNMR

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue SUPPL., 2013, Pages

  Fathi, Fariba ^a   Ektefa, Fatemeh ^b   Hagh Azali, Mehrdad ^c   Aghdaie, Hamid Asadzadeh ^c  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1h nmr; Chemometrics; Crohn disease; Metabonomics

Indexed keywords

3 METHYL 2 OXOVALERIC ACID; ALLANTOIN; BIOLOGICAL MARKER; CARBOXYLIC ACID; CARNITINE; MANNITOL; MANNOSE; METHANOL; UNCLASSIFIED DRUG; XYLOSE;

ALCOHOL BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; CHEMOMETRICS; CROHN DISEASE; DISEASE CLASSIFICATION; DNA MODIFICATION; GLUCOSE URINE LEVEL; HUMAN; LIPID BLOOD LEVEL; METABOLOMICS; PATTERN RECOGNITION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; ULCERATIVE COLITIS;

EID: 84888771257     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Ebbels TMD, Cavill R. Bioinformatic methods in NMRbased metabolic profiling. Prog Nucl Magn Reson Spectrosc 2009;55:361-74.
2. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2009;2:807-13.
3. Fathi F, Tafazzoli M, Mehrpour M, Shahidi G. Study of metabolic profiling Parkinson's disease. HealthMED 2013; 7:204-10.
4. Nicholson J, Lindon J, Holmes. E. Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-89.
5. German JB, Hammock BD, Watkins SM. Metabolomics: Building on a century of biochemistry to guide human health. Metabolomics 2005;1:3-9.
6. Hong Y-S, Hong KS, Park M-H, Ahn Y-T, Lee J-H, Huh C-S, et al. Metabonomic Understanding of Probiotic Effects in Humans With Irritable Bowel Syndrome. J Clin Gastroenterol 2011;45:415-25.
7. Bezabeh T, Somorjai RL, Smith ICP. MR metabolomics of fecal extracts:applications in the study of bowel diseases. Magn Reson Chem 2009;47:54-61.
8. Gall GL, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, et al. Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome. J Proteome Res 2011;10:4208-18.
9. Claridge TDW. High-resolution NMR techniques in organic chemistry. Elsevier Sciences Ltd; 1999.
10. Mehrpour M, Kyani A, Tafazzoli M, Fathi F, Joghataie M-T. A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance. Magn Reson Chem 2013;51:102-9.
11. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, et al. Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals. J Proteome Res 2012;11:3344-57.
12. Stephens NS, Siffledeen J, Su X, Murdoch TB, Fedorak RN, Slupsky CM. Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy. J Crohns Colitis 2012.
13. Fathi F, Kyani A, Nejad MR, Rezaye-Tavirani M, Naderi N, Zali MR, et al. A metabonomics study on Crohn's Disease using Nuclear Magnetic Resonance spectroscopy. HealthMED 2012;6:3577-84.
14. Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, Slupsky CM. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem. 2008 80:5524-31.
15. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease. J Proteome Res 2007;6:546-51.
16. Fathi F, Kyani A, Darvizeh F, Mehrpour M, Tafazzoli M, Shahidi G. Relationship Between Serum Level of Selenium and Metabolites Using 1 HNMR-Based Metabonomics in Parkinson's Disease. Appl Magn Reson 2013;44:721-34.
17. Craig A, Cloarec O, Holmes E, Nicholson JK, Lindon JC. Scaling and Normalization Effects in NMR Spectroscopic Metabonomic Data Sets. Anal Chem 2006;78:2262-7.
18. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. Scaling. In Introduction to multi- and megavariate data analysis using projection methods (PCA & PLS) Umetrics. 1999:213-25.
19. Rezaei-Tavirani M, Fathi F, Darvizeh F, Zali MR, Rostami Nejad M, Rostami K, et al. Advantage of Applying OSC to 1H NMR-Based Metabonomic Data of Celiac Disease. Int J Endocrinol Metab 2012 10:548-52.
20. Breiman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. Chapman &Hall (Wadsworth I, editor. New York; 1984.
21. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabolomics. J Proteome Res 2007;6:469-79.